0
(Adds overseas regulatory reviews in paragraph 9) Nov 18 (Reuters) – The US FDA on Wednesday approved Sanofi's oral drug venglustat, making it the first treatment for a type of rare genetic condition
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)